Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Trospium chloride
Drug ID BADD_D02306
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01103
MeSH ID C003330
PubChem ID 5284631
TTD Drug ID D0U9FD
NDC Product Code 0904-7059; 68462-461; 71205-917; 90096-141; 17337-0544; 65675-6294; 60429-098; 63629-9279; 76282-336; 66039-864; 50090-5994; 68001-427; 69097-912; 0574-0145; 42413-0108; 46016-1042; 63629-8458; 0574-0118; 63629-8457; 11014-0444; 14501-0054; 70010-027; 0591-3636; 23155-530; 70436-174
UNII 1E6682427E
Synonyms trospium chloride | azoniaspiro compound XVII | azoniaspiro(3 alpha-benziloyloxynortropane-8,1'- pyrrolidine) chloride | Spasmex | Uraton | Spasmolyt | Spasmo-Urgenin TC | Spasmo-lyt | Spasmo-Rhoival TC | Trospi | Ceris | Uraplex | Spasmo-Urgenin
Chemical Information
Molecular Formula C25H30ClNO3
CAS Registry Number 10405-02-4
SMILES C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain upper07.01.05.003--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Asthenia08.01.01.001--Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Constipation07.02.02.001--
Delirium19.13.02.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dry eye06.08.02.001--
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dry throat07.06.01.005; 22.12.03.005--Not Available
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Erythema multiforme23.03.01.003; 10.01.03.015--
Eye disorder06.08.03.001--Not Available
Fatigue08.01.01.002--
Flatulence07.01.04.002--
Gastritis07.08.02.001--
Gastrointestinal disorder07.11.01.001--Not Available
Hallucination19.10.04.003--
Headache17.14.01.001--
Hypertensive crisis24.08.01.001--Not Available
Loss of consciousness17.02.04.004--Not Available
Nervous system disorder17.02.10.001--Not Available
Palpitations02.11.04.012--
Rash23.03.13.001--Not Available
Rhabdomyolysis15.05.05.002--
The 1th Page    1 2    Next   Last    Total 2 Pages